美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
25021-652-82	25021-652	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride	ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20190715	N/A	ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	5 mg/mL	10 BAG in 1 CARTON (25021-652-82) / 100 mL in 1 BAG
25021-652-87	25021-652	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride	ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20190715	N/A	ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	5 mg/mL	10 BAG in 1 CARTON (25021-652-87) / 200 mL in 1 BAG
25021-671-82	25021-671	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride	ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20181215	N/A	ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	2 mg/mL	10 BAG in 1 CARTON (25021-671-82) / 100 mL in 1 BAG
25021-671-87	25021-671	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride	ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20181215	N/A	ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	2 mg/mL	10 BAG in 1 CARTON (25021-671-87) / 200 mL in 1 BAG
25021-671-66	25021-671	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride	ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20200101	N/A	ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	2 mg/mL	10 BAG in 1 CARTON (25021-671-66) / 100 mL in 1 BAG
25021-671-67	25021-671	HUMAN PRESCRIPTION DRUG	ropivacaine hydrochloride	ropivacaine hydrochloride	INJECTION, SOLUTION	EPIDURAL; INFILTRATION	20200101	N/A	ANDA	ANDA206166	Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE	2 mg/mL	10 BAG in 1 CARTON (25021-671-67) / 200 mL in 1 BAG